Population pharmacokinetic-pharmacodynamic modelling of 24-h diastolic ambulatory blood pressure changes mediated by axitinib in patients with metastatic renal cell carcinoma.
about
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.Axitinib: a review in advanced renal cell carcinoma.Exposure-response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults.Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.Quantifying the relationship between inhibition of VEGFR-2, drug-induced blood pressure elevation and hypertension.
P2860
Population pharmacokinetic-pharmacodynamic modelling of 24-h diastolic ambulatory blood pressure changes mediated by axitinib in patients with metastatic renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@en
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@nl
type
label
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@en
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@nl
prefLabel
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@en
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@nl
P2093
P2860
P1476
Population pharmacokinetic-pha ...... tastatic renal cell carcinoma.
@en
P2093
Angel H Bair
Brian I Rini
Ganesh M Mugundu
Yazdi K Pithavala
P2860
P2888
P304
P356
10.1007/S40262-014-0207-5
P577
2015-04-01T00:00:00Z
P6179
1017667037